Isomorphic Labs raised $5 billion in a Series C funding round co-led by Greenoaks and Sequoia Capital on Tuesday morning. The Alphabet-backed AI drug discovery company is using the capital to advance its first therapeutic candidates into clinical trials. The round follows a $2.1 billion Series B financing secured six months prior.
Isomorphic Raises Five Billion in Series C
Alphabet backed Isomorphic Labs has secured five billion dollars in a Series C funding round to advance its AI drug design engine and move therapeutic programs into clinical trials.
Xurve View
Insights:
Xurve View










